[ad_1]

Aspen City Council members say it’s not municipal government’s place to advocate for psilocybin mushrooms as part of psychedelic therapy.

ASPEN, Colo. — The majority of Aspen City Council on Monday shot down any notion that the municipal government ought to join the movement to promote psychedelic-assisted therapies as suggested by Councilman Skippy Mesirow.

Specifically, psilocybin, the psychoactive ingredient found in mushrooms, remains a schedule 1 drug by the federal government, and Aspen has no place in attempting to remove that classification, council members agreed during a work session.

“I don’t want to be on the bleeding edge on this one,” said Councilwoman Rachel Richards, adding it’s for agencies like the Food and Drug Administration, the Colorado Public Health and Environment and the U.S. Drug Enforcement Administration to sort out. “I think there could be some beneficial uses for people and I would support allowing such treatments within our community when there have been federal protocols developed and it is a monitored practice in the appropriate safe settings.”

Mesirow first introduced the concept of psychedelic-assisted therapies along with psychotherapy to help with mental health issues, whether it’s suicidal thoughts, depression, Post Traumatic Stress Disorder or addiction.

“I brought this forward because our community has had a mental health crisis for a long time,” Mesirow told his fellow council members on Monday, making a case for Aspen to use the world stage and take a leadership role in healing, mental illness and mental health. “We have four X the national suicide rate, we have two to three times the rate of anxiety, depression, substance abuse, and COVID has made this stuff worse.”

Read the full story in the Aspen Times. 

> Watch video above: Denver leaders and psilocybin mushroom advocates meet formally

RELATED: News reports lead DEA to alleged mushroom dealer in Denver

RELATED: Denver leaders, psilocybin mushroom advocates meet formally

SUGGESTED VIDEOS: Politics 


[ad_2]

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here